Kiniksa Pharmaceuticals L... (KNSA)
22.46
-0.63 (-2.73%)
At close: Mar 31, 2025, 10:18 AM
Kiniksa Pharmaceuticals Ltd. Ratios Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 |
| PE Ratio | -32.71 | 87.25 | 5.67 | -5.11 | -6.77 | -3.69 | -8.04 | -9.74 | -26.37 |
| PEG Ratio | 0.08 | -0.94 | -0.03 | 0.43 | 0.53 | 0.26 | -0.11 | -0.06 | n/a |
| PS Ratio | 3.34 | 4.55 | 4.72 | 20.94 | n/a | n/a | n/a | n/a | n/a |
| PB Ratio | 3.22 | 2.80 | -2.11 | -1.2 | -2.11 | -1.68 | -4.27 | -7.05 | -24.57 |
| P/FCF Ratio | 55.59 | 93.30 | 182.28 | -5.5 | -7.99 | -3.7 | -9.62 | -12.57 | -28.9 |
| P/OCF Ratio | 55.00 | 92.39 | 178.98 | -6.39 | -8 | -3.77 | -10.25 | -12.59 | -28.91 |
| OCF/S Ratio | 0.06 | 0.05 | 0.03 | -3.28 | n/a | n/a | n/a | n/a | n/a |
| Debt / Equity Ratio | 0.02 | 0.03 | -0.01 | -0.01 | -0.01 | -0.01 | n/a | n/a | n/a |
| Quick Ratio | 3.04 | 3.85 | 4.71 | 4.30 | 10.46 | 8.68 | 7.37 | 2.70 | 24.47 |
| Current Ratio | 3.30 | 4.34 | 5.16 | 4.38 | 10.46 | 8.68 | 7.37 | 2.70 | 24.47 |
| Asset Turnover | 0.73 | 0.51 | 0.48 | 0.17 | n/a | n/a | n/a | n/a | n/a |
| Interest Coverage | n/a | n/a | 5.88 | n/a | n/a | n/a | n/a | n/a | n/a |
| Return on Equity (ROE) | -0.1 | 0.03 | -0.37 | 0.23 | 0.31 | 0.45 | 0.53 | 0.72 | 0.93 |
| Return on Assets (ROA) | -0.07 | 0.03 | 0.40 | -0.68 | -0.46 | -0.64 | -0.32 | -1.37 | -0.42 |
| Return on Capital (ROIC) | -0.1 | -0.05 | 0.02 | -0.83 | -0.5 | -0.75 | -0.39 | -2.18 | -0.44 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | 100.00% | 79.09% | 78.67% | 76.39% | n/a | n/a | n/a | n/a | n/a |
| Net Profit Margin | -10.21% | 5.21% | 83.28% | -409.72% | n/a | n/a | n/a | n/a | n/a |
| Pretax Profit Margin | -8.54% | -6.16% | 5.01% | -406.13% | n/a | n/a | n/a | n/a | n/a |
| Operating Profit Margin | -10.78% | -9.32% | 3.35% | -406.38% | n/a | n/a | n/a | n/a | n/a |
| FCF Margin | 6.00% | 4.87% | 2.59% | -380.64% | n/a | n/a | n/a | n/a | n/a |
| EBITDA Margin | -10.78% | -8.46% | 4.44% | -400.27% | n/a | n/a | n/a | n/a | n/a |